2m 2m 2m 2m 2m 2m 2m
BETA BIONICS (BBNX)
NASDAQ
$12.59-$0.20 (-1.60%)
Price as of Jun 03, 2026 6:22 PM EDT- $540.1MMarket Cap
- -28.79%1-Year Change
- Medical DevicesIndustry
BETA BIONICS (BBNX)
$12.59-$0.20 (-1.60%)
BBNX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $12.79 | ||
Change | -$0.01 (-0.08%) | ||
Open | $12.54 | ||
High | $12.95 | ||
Low | $12.29 | ||
Previous Close | $12.80 | ||
Volume | 900,372 | ||
30-Day Average Volume | 697,860 | ||
1-Week Change | 9.13% | ||
1-Month Change | 24.30% | ||
1-Year Change | -28.79% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 44.6M | ||
Total Assets | $304.4M | ||
Market Cap | $540.1M | ||
Enterprise Value | $509.9M | ||
Period: QTR TTM FY | |||
Revenue | $27.6M | ||
Net Income | -$21.9M | ||
Free Cash Flow | -$25.2M | ||
EBIT | -$21.9M | ||
EBITDA | -$21.3M | ||
Net Working Capital | $224.8M | ||
EPS | -$0.49 | ||
Enterprise Value/EBITDA | -24 | ||
Enterprise Value/Revenue | 18 | ||
P/B | 2 | ||
P/E | -25 | ||
PEG | 0 | ||
Price/Free Cash Flow | -21 | ||
Price/Operating Cash Flow | -23 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue